# Antibiotic Resistance in Acetic Acid Bacteria Originating from Vinegar

**Authors:** Sun-Hee Kim, Hyun-Wook Jang, Jin-Ju Park, Dong-Geon Nam, Su-Jeong Lee, Soo-Hwan Yeo, So-Young Kim

PMC · DOI: 10.3390/antibiotics13070626 · Antibiotics · 2024-07-05

## TL;DR

This study examines antibiotic resistance in acetic acid bacteria used in vinegar production, revealing resistance patterns and intrinsic mechanisms that could impact food safety and antimicrobial strategies.

## Contribution

The study identifies intrinsic resistance mechanisms in acetic acid bacteria and highlights the need for standardized testing and molecular genetic research.

## Key findings

- All AAB strains showed resistance to aztreonam and clindamycin.
- Komagataeibacter species had higher resistance to chloramphenicol and erythromycin compared to Acetobacter.
- Genomic analysis revealed multidrug efflux pumps in K. saccharivorans CV1.

## Abstract

Acetic acid bacteria (AAB) are major contributors to the production of fermented vinegar, offering various cultural, culinary, and health benefits. Although the residual unpasteurized AAB after vinegar production are not pathogens, these are necessary and require safety evaluations, including antibiotic resistance, before use as a starter. In this research, we investigated the antibiotic resistance profiles of 26 AAB strains, including various species of Komagataeibacter and Acetobacter, against 10 different antibiotics using the E-test method. All strains exhibited resistance to aztreonam and clindamycin. Komagataeibacter species demonstrated a 50% resistance rate to ciprofloxacin, analogous to Acetobacter species, but showed twice the resistance rates to chloramphenicol and erythromycin. Genomic analysis of K. saccharivorans CV1 identified intrinsic resistance mechanisms, such as multidrug efflux pumps, thereby enhancing our understanding of antibiotic resistance in acetic acid-producing bacteria. These findings enhance understanding of antibiotic resistance in AAB for food safety and new antimicrobial strategies, suggesting the need for standardized testing methods and molecular genetic study.

## Linked entities

- **Chemicals:** aztreonam (PubChem CID 5742832), clindamycin (PubChem CID 446598), ciprofloxacin (PubChem CID 2764), chloramphenicol (PubChem CID 5959), erythromycin (PubChem CID 12560)
- **Species:** Komagataeibacter (taxon 1434011), Acetobacter (taxon 434)

## Full-text entities

- **Chemicals:** ciprofloxacin (MESH:D002939), chloramphenicol (MESH:D002701), acetic acid (MESH:D019342), aztreonam (MESH:D001398), erythromycin (MESH:D004917), clindamycin (MESH:D002981)
- **Species:** Komagataeibacter (genus) [taxon 1434011], Acetobacter subgen. Acetobacter (subgenus) [taxon 151157]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11274321/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11274321/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC11274321/full.md

---
Source: https://tomesphere.com/paper/PMC11274321